|
Volumn 15, Issue 1, 1999, Pages 35-38
|
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 plus the pineal oncostatic hormones melatonin and 5-methoxytryptamine in untreatable advanced solid neoplasm patients with very poor clinical status
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
5 METHOXYTRYPTAMINE;
MELATONIN;
RECOMBINANT INTERLEUKIN 2;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER IMMUNOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
IMMUNOMODULATION;
MALE;
NEUROIMMUNOLOGY;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
SOLID TUMOR;
SUBCUTANEOUS DRUG ADMINISTRATION;
|
EID: 0032816644
PISSN: 02559625
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (10)
|